Background: Lower plaque trauma may result in favorable late outcomes after coronary stenting. The Sparrow® Coronary Stent System (CardioMind, Inc. Sunnyvale, CA) is a 0.014" guidewire-based stent delivery platform combining the Sirolimus drug in a fully biodegradable SynBiosys polymer matrix on CardioMind's nitinol stent platform. Stent release is achieved with a novel release mechanism which utilizes a principle of electrochemical dissolution. Both the Bare metal (BMS) and sirolimus eluting (DES) versions are under evaluation in the CARE II randomized clinical study.
